Related Experiment Video
Updated: Sep 12, 2025

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
Published on: April 17, 2020
Acid suppression after esophageal atresia repair: Some infants do benefit
Suhail Zeineddin1,2, Gwyneth A Sullivan1,2,3, J Benjamin Pitt1,2
1Division of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Insights
Acid suppression therapy may reduce stricture rates in infants undergoing complex esophageal atresia/tracheoesophageal fistula (EA/TEF) repair. For simple EA/TEF cases, acid suppression showed no significant benefit in preventing anastomotic strictures.
Area of Science:
- Pediatric Surgery
- Gastroenterology
- Neonatal Care
Background:
- Acid suppression is commonly used post-esophageal atresia/tracheoesophageal fistula (EA/TEF) repair to prevent anastomotic strictures.
- Recent evidence has questioned the efficacy of acid suppression in this context.
- This study investigates the association between acid suppression and stricture rates in a large infant cohort.
Purpose of the Study:
- To compare anastomotic stricture rates in infants undergoing EA/TEF repair with and without acid suppression.
- To determine if acid suppression is beneficial for preventing strictures in simple versus complex EA/TEF cases.
Main Methods:
- A nationwide sample of infants undergoing EA/TEF repair (2010-2022) was analyzed using the Pediatric Health Information System.
- Acid suppression was defined by H2 blocker or PPI use.
- Complex EA/TEF repair included criteria like delayed repair, G-tube placement, prolonged hospitalization, or multiple fluoroscopies. Stricture dilation was the primary outcome.
Main Results:
- Among 1445 infants, 17.8% required dilation by 1 year.
- For simple EA/TEF, stricture rates were similar with or without acid suppression (17.5% vs. 17.0%, p=0.90).
- In complex EA/TEF cases, those receiving acid suppression had significantly lower stricture rates (15.3% vs. 26.0%, p=0.001).
Conclusions:
- Postoperative acid suppression is associated with reduced stricture incidence in complex EA/TEF repair.
- Reducing acid suppression may be appropriate for simple EA/TEF repairs.
- Acid suppression should be considered for infants with complex EA/TEF to mitigate stricture risk.
Background:
Acid suppression is used to protect against anastomotic strictures after esophageal atresia/tracheoesophageal fistula (EA/TEF) repair, but recent studies have contested this benefit. We aimed to compare rates of anastomotic stricture following EA/TEF repair among patients who received and did not receive acid suppression in a nationwide sample.
Methods:
We queried the Pediatric Health Information System for infants undergoing EA/TEF repair between 2010 and 2022. Acid suppression was defined as receipt of an H2 blocker or proton pump inhibitor on the day of discharge or longer than 30 inpatient days. Complex EA/TEF repair was defined as delayed repair (>7 days), G-tube placement before repair, prolonged hospitalization (>60 days), or multiple inpatient fluoroscopies. Stricture dilation defined the outcome.
Results:
Of 1445 infants included from 47 hospitals, 257 (17.8%) required dilation by 1 year. Of the 688 (47.6%) infants who met criteria for complex EA/TEF, 126 (18.6%) required a dilation. Prolonged acid suppression was given in 977 (67.6%) infants. At 1 year, stricture rate was similar in infants with simple EA/TEF, with or without acid suppression (17.5% vs. 17.0%, p = 0.90), however, in infants with complex EA/TEF, stricture rates were lower among those who received acid suppression compared to those who did not (15.3% vs. 26.0%, p = 0.001).
Conclusion:
In patients with complex EA/TEF, those who received postoperative acid suppression had a lower incidence of stricture. While it is reasonable to reduce the use of acid suppression after simple EA/TEF repair, infants with complex EA/TEF should receive acid suppression to reduce the risk of stricture.
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...

